SUNHO BIO-B(02898): Fan Rongkui terminates his appointment as non-executive director.
Shenghe Biotechnology-B (02898) announced that, upon the expiration of the term stipulated in the service contract entered into with Mr. Fan Rongkui, Mr. Fan Rongkui will cease to serve as a non-executive director starting from July 22, 2026.
SUNHO BIO-B (02898) announced that after the expiration of the term specified in the service contract entered into with Mr. Fan Rongkui, as of July 22, 2026, Mr. Fan Rongkui will cease to serve as a non-executive director.
Related Articles
US Stock Market Move | Halliburton (HAL.US) fell nearly 6% as Q3 revenue guidance weakened.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises more than 3%, the market expects a year-on-year increase of nearly 30% in Q2 earnings per share.
CARRY WEALTH (00643): Chen Huiying appointed as executive director.
US Stock Market Move | Halliburton (HAL.US) fell nearly 6% as Q3 revenue guidance weakened.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises more than 3%, the market expects a year-on-year increase of nearly 30% in Q2 earnings per share.
CARRY WEALTH (00643): Chen Huiying appointed as executive director.
RECOMMEND
